MIT Study Links Keto Diet to Increased Cancer Risk in Mice

Researchers at the Massachusetts Institute of Technology (MIT) have identified a potential hidden cancer risk associated with the ketogenic diet, specifically an increase in small-intestinal tumors in mice genetically predisposed to cancer. The study, published in the journal Nature Metabolism, observed that while the ketogenic diet reduced tumors in the colon, it paradoxically led to a higher incidence of tumors in the small intestine. This finding highlights a complex and differential impact of the diet on various parts of the gastrointestinal tract.

The research team, led by Dr. Navdeep Chandel, a professor of cell biology at Northwestern University Feinberg School of Medicine, and Dr. Kyu-won Kim, a postdoctoral fellow at MIT, investigated the underlying mechanisms driving this observed tumor increase. They determined that the heightened risk was not directly attributable to the high levels of ketones produced during ketosis, a metabolic state achieved by drastically reducing carbohydrate intake. Instead, the researchers traced the problem to how intestinal stem cells processed the diet's abundant fat content.

Specifically, the study found that intestinal stem cells, when fueled by the high-fat diet, increased their fat-burning activity. This enhanced metabolic process prompted the stem cells to multiply at a more rapid rate. The accelerated proliferation of these cells, which are responsible for tissue regeneration and repair, could potentially increase the likelihood of accumulating the genetic mutations necessary for cancerous transformation. This mechanism suggests that the rapid cell division, rather than the presence of ketones themselves, is the critical factor in promoting tumor development in the small intestine.

The ketogenic diet, characterized by its very low carbohydrate, moderate protein, and high-fat composition, has gained popularity for its potential benefits in weight loss and managing conditions like epilepsy. However, this new research from MIT raises significant concerns about its long-term safety and potential oncogenic effects, particularly in individuals with a predisposition to certain cancers. The study's findings underscore the importance of further investigation into the nuanced metabolic effects of dietary interventions and their implications for cellular health and disease prevention. The researchers emphasize that their findings are based on studies in mice and further research is needed to determine if these effects translate to humans.